Skip to content

Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Development of Clinical Database of Individuals With Smith-Magenis Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03154697
Enrollment
1000
Registered
2017-05-16
Start date
2016-01-31
Completion date
2030-12-31
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbances in Smith-Magenis Syndrome

Brief summary

This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.

Interventions

OTHERData collection of sleep disturbances in individuals with SMS

Data related to Smith-Magenis syndrome and sleep disturbances are collected through a web or phone survey

Sponsors

Vanda Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Parent or legal guardian of individual with Smith-Magenis Syndrome

Exclusion criteria

* Not legal guardian of individual with SMS

Design outcomes

Primary

MeasureTime frame
Number of individuals with Smith- Magenis syndrome5 years

Secondary

MeasureTime frame
Sleep DisturbancesUp to 100 weeks

Countries

United States

Contacts

Primary ContactVanda Pharmaceuticals
clinicaltrials@vandapharma.com202-734-3400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026